BioTech Helsinki Makes Debut


Helsinki - Finland's new biotechnology event “BioTech Helsinki 03” attracted more than 3,300 visitors from March 24 to 26. The event comprised a top-level international conference with 600 participants with topics ranging from bioethics and genome research to biomaterials and brain research. The exhibition with 135 exhibitors, amongs which some 35 from abroad, was organised by the Finnish Fair Corporation in co-operation with Finnish Bioindustries, Sitra (National Fund for Research and Development) and Tekes (National Technology Agency), who organised the conference. A joint investment day with about 150 participants rounded off the programme.
“The companies selected to present their business and fund-raising plans to international investors and venture capitalists had products that are ready for the markets or they operate in a niche area”, said Mike Ward, director of Critical I Ltd. and one of the directors of the UK's BioIndustry Association (BIA). According to Hannu Hanhijärvi, Director of Sitra Life Sciences, “the Investor Forum provided a chance for international investors to get acquainted with Finnish biotechnology know-how. Around 40 investors from Finland, Sweden, Denmark, Great Britain, Belgium, Germany and the US were participating.”
The first BioTech Helsinki Prize, endowed with Euro50,000 by Sitra, was awarded to Prof. Dr. Patrick O. Brown from Stanford University. Brown and his collegues developed a high-density DNA-array that uses nucleic acid hybridization to monitor thousands of genes simultaneously.



The vaccine research centre of the University of Tampere in Finland has out­licenced a candidate combined prophylactic vaccine against norovirus and rota­virus infections. The Japanese vaccine venture UMN Pharma Inc. acquired the...



Finnish protein manufacturer Vectron Biosolutions AS has completed a study comparing different expression technologies. According to Vectron, their proprietary E. coli expression technology gave higher yields for seven out of ten...



Lappeenranta – Finnish paper industry major UPM plans to invest in an industry-scale biorefinery producing biofuels from crude tall oil, a by-product of the wood pulp manufacturing process. UPM’s total investment will amount to...



Helsinki/Göttingen – Finnish laboratory supplier Biohit Oyj has sold its liquid handling business for €68m to German process and labtech provider Sartorius AG. Osmo Suovaniemi, founder and Chairman of the Board at Biohit,...



Porvoo/Chalfont St. Giles – GE Healthcare and Neste Jacobs have formed a strategic alliance to drive worldwide self-sufficiency in blood plasma fractionation. Finnish-based Neste Jacobs Oy, a global expert in plant engineering...



Bresso/Turku – The wedding's off between Newron and Biotie. The bride has run away. Shares in Italy's Newron Pharmaceuticals plunged after its proposed merger with Biotie Therapies Corp was called off by the Finnish firm....



Turku/ Bresso – It is both good and bad news for the Italian biotechnology sector: Finnish Biotie Therapies ASA has signed an agreement to acquire Newron Pharmaceuticals S.p.A. for €45 million. On the down side, Italy loses one...



Hafnarfjodur – Actavis Group CEO Claudio Albrecht announced at the beginning of February that the company may go public within the next 2-3 years, although it isn’t clear whether the generics manufacturer would conduct an IPO,...

Displaying results 1 to 10 out of 96

1-10 Next >

© 2007-2015 BIOCOM


All Events


Product of the week


Current issue

All issues